Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | APEX1 | P27695 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | RXRA | P19793 | 1/20 | 0.44 |
| ▸ | RXRB | P28702 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 4/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | PPARD | Q03181 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27551550 | 0.91 | TDP1 (0.68) | POLBTDP1APEX1HTTRXRA | |
| SCHEMBL4451622 | 0.91 | TDP1 (0.56) | POLBTDP1APEX1HTTKMT2A | |
| SCHEMBL14870427 | 0.91 | HTT (0.48) | POLBTDP1APEX1HTTRXRA | |
| SCHEMBL16620120 | 0.90 | TDP1 (0.55) | POLBTDP1APEX1HTTKMT2A | |
| SCHEMBL15698361 | 0.89 | TDP1 (0.57) | POLBTDP1APEX1HTTKMT2A | |
| SCHEMBL454606 | 0.89 | POLB (0.67) | POLBTDP1APEX1HTTKMT2A | |
| SCHEMBL22648799 | 0.89 | HTT (0.46) | POLBTDP1APEX1HTTKMT2A | |
| SCHEMBL25784256 | 0.87 | TDP1 (0.56) | POLBTDP1APEX1HTTKMT2A | |
| SCHEMBL13636409 | 0.87 | TDP1 (0.52) | POLBTDP1APEX1HTTKMT2A | |
| SCHEMBL31040362 | 0.86 | TDP1 (0.51) | POLBTDP1APEX1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115403711-B | Transparent material composition for three-dimensional molding, and preparation method and application thereof | 珠海赛纳三维科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-114796618-B | Dental material for manufacturing temporary crowns and bridges | 义获嘉伟瓦登特公司 | 2024-04-26 | — | — | CN | claimed |
| EP-3622942-B1 | POLYMERIC MATERIALS WITH UNSATURATED TRANSMISSION REAGENTS | IVOCLAR VIVADENT AG (LI) | 2024-01-17 | — | — | EP | claimed |
| US-20230265220-A1 | Photopolymerizable Dental Composites With Rapid Curing And Low Shrinkage Stress | IVOCLAR VIVADENT AG (LI) | 2023-08-24 | — | — | US | claimed |
| US-11673980-B2 | Photopolymerizable dental composites with rapid curing and low shrinkage stress | IVOCLAR VIVADENT AG (LI) | 2023-06-13 | — | — | US | claimed |
| CN-114796618-A | Dental material for producing temporary crowns and bridges | 义获嘉伟瓦登特公司 | 2022-07-29 | — | — | CN | claimed |
| US-12357440-B2 | Container for producing a dental synthetic material composition | IVOCLAR VIVADENT AG (LI) | 2025-07-15 | — | — | US | disclosed |
| CN-115403711-B | Transparent material composition for three-dimensional molding, and preparation method and application thereof | 珠海赛纳三维科技有限公司 | 2025-04-18 | — | — | CN | disclosed |
| US-20240058110-A1 | CONTAINER FOR PRODUCING A DENTAL SYNTHETIC MATERIAL COMPOSITION | IVOCLAR VIVADENT AG (LI) | 2024-02-22 | — | — | US | disclosed |
| EP-3622942-B1 | POLYMERIC MATERIALS WITH UNSATURATED TRANSMISSION REAGENTS | IVOCLAR VIVADENT AG (LI) | 2024-01-17 | — | — | EP | disclosed |
| US-11833005-B2 | Container for producing a dental synthetic material composition | IVOCLAR VIVADENT AG (LI) | 2023-12-05 | — | — | US | disclosed |
| US-20230265220-A1 | Photopolymerizable Dental Composites With Rapid Curing And Low Shrinkage Stress | IVOCLAR VIVADENT AG (LI) | 2023-08-24 | — | — | US | disclosed |
| US-11673980-B2 | Photopolymerizable dental composites with rapid curing and low shrinkage stress | IVOCLAR VIVADENT AG (LI) | 2023-06-13 | — | — | US | disclosed |
| EP-1116580-A2 | Lithographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 2001-07-18 | — | — | EP | disclosed |
| EP-1106381-A1 | Planographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 2001-06-13 | — | — | EP | disclosed |
| EP-1081552-A1 | Lithographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 2001-03-07 | — | — | EP | disclosed |
| EP-0520364-B1 | Photopolymerizable composition | FUJI PHOTO FILM CO LTD (JP) | 1997-09-17 | — | — | EP | disclosed |
| US-5385807-A | Photopolymerizable composition | FUJI PHOTO FILM CO., LTD. (JP) | 1995-01-31 | — | — | US | disclosed |
| EP-0520364-A1 | Photopolymerizable composition | FUJI PHOTO FILM CO., LTD. (JP) | 1992-12-30 | — | — | EP | disclosed |
| EP-0399755-A1 | Light-sensitive composition and presensitized plate for use in making lithographic printing plates | Fuji Photo Film Co., Ltd. (JP) | 1990-11-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265220-A1 | Photopolymerizable Dental Composites With Rapid Curing And Low Shrinkage Stress | MMAB, ALAD, SULT1E1 | POLB 1242/4885TDP1 2537/4885APEX1 463/4885 |
| US-11673980-B2 | Photopolymerizable dental composites with rapid curing and low shrinkage stress | MMAB, ALAD, SULT1E1 | POLB 1242/4885TDP1 2537/4885APEX1 463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.